Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ FGL1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5100528
Description
Antibody detects endogenous levels of total FGL1.
Fibrinogen-like 1 is a member of the fibrinogen family. This protein is homologous to the carboxy terminus of the fibrinogen beta- and gamma- subunits which contains the four conserved cysteines of fibrinogens and fibrinogen related proteins. However, this protein lacks the platelet-binding site, cross-linking region and a thrombin-sensitive site which are necessary for fibrin clot formation. This protein may play a role in the development of hepatocellular carcinomas. Four alternatively spliced transcript variants encoding the same protein exist for this gene.
Specifications
FGL1 | |
Polyclonal | |
Unconjugated | |
FGL1 | |
Fgl1; fibrinogen like 1; fibrinogen-like 1; fibrinogen-like protein 1; Fibrinogen-related protein 1; fibronigen-like protein 1; Frep1; Hepassocin; hepatocellular carcinoma-related sequence; hepatocyte-derived fibrinogen-related protein 1; HFREP1; HFREP-1; HP-041; HPS; Lfire1; LFIRE-1; Liver fibrinogen-related protein 1; Liver fibrinogen-related protein-1; Mfire1; Mfire-1; Mfrep-1; MGC12455; OTTHUMP00000122468 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
2267, 234199, 246186 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q08830, Q5M8C6, Q71KU9 | |
FGL1 | |
A synthesized peptide derived from human FGL1(Accession Q08830), corresponding to amino acid residues F108-N158. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction